The effect of CYP2E1-dependent oxidant stress on activity of proteasomes in HepG2 cells

被引:27
|
作者
Kessova, IG [1 ]
Cederbaum, AI [1 ]
机构
[1] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA
关键词
D O I
10.1124/jpet.105.088047
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A reduction in proteasome activity and accumulation of oxidized proteins may play a role in alcoholic liver disease. The current study assessed proteasome peptidase activities and oxidative modifications of proteasomes during oxidative stress generated by CYP2E1. The model of toxicity by arachidonic acid (AA) and iron [ferric-nitrilotriacetate (Fe-NTA)] in HepG2 cells overexpressing CYP2E1 (E47 cells) and control C34 cells was used. AA/Fe-NTA treatment decreased trypsin-like (T-L) activity of the proteasome in E47 cells but not in C34 cells. This inhibition was abolished by antioxidants. Chymotrypsin-like activity of the proteasome was increased in E47 cells, and activity was not altered by AA/Fe-NTA treatment. There were no changes in content of subunits of 20S proteasomes or 19S regulator ATPase subunits S4 and p42 by AA/Fe-NTA treatment. An increased content of the PA28 alpha subunit of the 11S regulator of proteasomes was detected in E47 cells. In proteasome pellets, the decline of T-L activity was accompanied by increased content of carbonyl adducts, suggesting oxidative modification of proteasomes. Higher levels of ubiquitinated, 3-nitrotyrosine- and 4-hydroxynonenal-modified proteins and lower levels of free ubiquitin were detected in untreated E47 cells in comparison with C34 cells. Accumulation of protein cross-linked, detergent-insoluble aggregates was increased with AA/Fe-NTA treatment in E47 cells. Thus, reactive oxygen species generated upon CYP2E1-dependent oxidative stress mediated a decline in T-L proteasome function, increased carbonyl adducts in proteasomes, and promoted protein aggregate formation; this may alter the balance among protein oxidation, ubiquitination, and degradation.
引用
收藏
页码:304 / 312
页数:9
相关论文
共 50 条
  • [41] Lycopene attenuates alcohol-induced apoptosis and oxidative stress in HepG2 cells overexpressing CYP2E1
    Xu, YQ
    Leo, MA
    Lieber, CS
    GASTROENTEROLOGY, 2003, 124 (04) : A719 - A719
  • [42] Effect of Functionalized CdSSe Quantum Dots in the CYP450 Activity of HEPG2 Cells
    Alamo-Nole, Luis
    Cruz-Hernandez, Jury
    MICRO-SWITZERLAND, 2023, 3 (02): : 391 - 403
  • [43] Regulation of rabbit CYP2E1 expression in HepG2 cells by insulin and thyroid hormone
    Peng, HM
    Coon, MJ
    FASEB JOURNAL, 1997, 11 (09): : A820 - A820
  • [44] Histone acetylation and arachidonic acid cytotoxicity in HepG2 cells overexpressing CYP2E1
    A. Holownia
    R. M. Mroz
    P. Wielgat
    P. Jakubow
    J. Jablonski
    J. Sulek
    J. J. Braszko
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2014, 387 : 271 - 280
  • [45] Role of the proteasome complex in degradation of human CYP2E1 in transfected HepG2 cells
    Yang, MX
    Cederbaum, AI
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 226 (03) : 711 - 716
  • [46] Lycopene attenuates arachidonic acid toxicity in HepG2 cells overexpressing CYP2E1
    Xu, YQ
    Leo, MA
    Lieber, CS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 303 (03) : 745 - 750
  • [47] Synergistic toxicity of iron and arachidonic acid in HepG2 cells overexpressing CYP2E1
    Caro, AA
    Cederbaum, AI
    MOLECULAR PHARMACOLOGY, 2001, 60 (04) : 742 - 752
  • [48] Removal of glutathione produces apoptosis and necrosis in HepG2 cells overexpressing CYP2E1
    Wu, DF
    Cederbaum, AI
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2001, 25 (04) : 619 - 628
  • [49] Histone acetylation and arachidonic acid cytotoxicity in HepG2 cells overexpressing CYP2E1
    Holownia, A.
    Mroz, R. M.
    Wielgat, P.
    Jakubow, P.
    Jablonski, J.
    Sulek, J.
    Braszko, J. J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2014, 387 (03) : 271 - 280
  • [50] The effect of ethanol and nitric oxide on the N-nitrosodimethylamine formation in HepG2 cells overexpressing CYP2E1
    Jablonski, J
    Holownia, A
    Jablonska, E
    Moniuszko-Jakoniuk, J
    Braszko, J
    Iwanowska, J
    Marcinczyk, M
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2005, 24 (09) : 447 - 452